---
layout: ../../layouts/Publication.astro
title: Signature reversion of three disease-associated gene signatures prioritizes cancer drug repurposing candidates.
journal: FEBS open bio
authors: Fisher JL, Wilk EJ, Oza VH, Gary SE, Howton TC, Flanary VL, Clark AD, Hjelmeland AB, Lasseigne BN
year: 2024
page: 803-830
volume: 14
issue: 5
pmid: 38531616.0
pmcid: PMC11073506
doi: 10.1002/2211-5463.13796
landmark: False
carousel: False
featured: False
r03: R03OD030604
keywords: ["Gene Expression Profiling", "cancer", "Drug Repositioning", "glioblastoma", "Animals", "Glioblastoma", "Gene Expression Regulation, Neoplastic", "gene signature", "Mice", "Brain Neoplasms", "transcriptomic signature", "Xenograft Model Antitumor Assays", "Transcriptome", "Antineoplastic Agents", "Neoplasms", "Cell Line, Tumor", "drug repurposing", "Humans"]
---